FDA Panel to Review Modernas New Flu Vaccine as Approval Decision...

paylaşılan bir bağlantı

2026-06-18 14:00:04

FDA Panel to Review Modernas New Flu Vaccine as Approval Decision Approaches

BY MIRABEL ODETAThe U.S. Food and Drug Administrations advisory panel is preparing to vote on whether the benefits of Modernas flu vaccine, mFlusiva, outweigh its potential risks in older adults.

0 Yorumlar 0 hisse senetleri 18 Views